{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T06:53:40Z","timestamp":1793429620068,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,8]],"date-time":"2022-01-08T00:00:00Z","timestamp":1641600000000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006197","name":"Fonden til L\u00e6gevidenskabens Fremme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ghadvances.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastro Hep Advances"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.gastha.2021.12.007","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T14:40:46Z","timestamp":1648651246000},"page":"299-312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Enterohepatic, Gluco-metabolic, and Gut Microbial Characterization of Individuals With Bile Acid Malabsorption"],"prefix":"10.1016","volume":"1","author":[{"given":"Martin L.","family":"K\u00e5rhus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Sonne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Thomasen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Ellegaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens J.","family":"Holst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens F.","family":"Rehfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Ch\u00e1vez-Talavera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Tailleux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"Staels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis S.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukasz","family":"Krych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars O.","family":"Dragsted","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Vilsb\u00f8ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Br\u00f8nden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2495-5034","authenticated-orcid":false,"given":"Filip K.","family":"Knop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gastha.2021.12.007_bib1","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1365-2036.2009.04081.x","article-title":"Systematic review: the prevalence of idiopathic bile acid malabsorption as diagnosed by SeHCAT scanning in patients with diarrhoea-predominant irritable bowel syndrome","volume":"30","author":"Wedlake","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastha.2021.12.007_bib2","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/1756283X10377126","article-title":"Managing bile acid diarrhoea","volume":"3","author":"Walters","year":"2010","journal-title":"Ther Adv Gastroenterol"},{"key":"10.1016\/j.gastha.2021.12.007_bib3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1136\/flgastro-2019-101301","article-title":"Diagnosis and management of bile acid diarrhoea: a survey of UK expert opinion and practice","volume":"11","author":"Walters","year":"2020","journal-title":"Frontline Gastroenterol"},{"key":"10.1016\/j.gastha.2021.12.007_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cgh.2009.10.020","article-title":"Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function","volume":"8","author":"Odunsi-Shiyanbade","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2021.12.007_bib5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.7861\/clinmedicine.15-3-252","article-title":"Quantifying bile acid malabsorption helps predict response and tailor sequestrant therapy","volume":"15","author":"Orekoya","year":"2015","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.gastha.2021.12.007_bib6","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1016\/j.cgh.2020.02.027","article-title":"Effects of colesevelam on bowel symptoms, biomarkers, and colonic mucosal gene expression in patients with bile acid diarrhea in a randomized trial","volume":"18","author":"Vijayvargiya","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2021.12.007_bib7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.5009\/gnl14397","article-title":"Bile acid diarrhea: prevalence, pathogenesis, and therapy","volume":"9","author":"Camilleri","year":"2015","journal-title":"Gut Liver"},{"key":"10.1016\/j.gastha.2021.12.007_bib8","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.14309\/ajg.0000000000000696","article-title":"The role of bile acids in chronic diarrhea","volume":"115","author":"Camilleri","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastha.2021.12.007_bib9","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/apt.12684","article-title":"Systematic review: the management of chronic diarrhoea due to bile acid malabsorption","volume":"39","author":"Wilcox","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.gastha.2021.12.007_bib10","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.cgh.2009.04.024","article-title":"A\u00a0new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis","volume":"7","author":"Walters","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2021.12.007_bib11","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/nrd2619","article-title":"Targeting bile-acid signalling for metabolic diseases","volume":"7","author":"Thomas","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.gastha.2021.12.007_bib12","first-page":"16","article-title":"The role of bile acids in glucose metabolism and their relation with diabetes","volume":"16","author":"Gonz\u00e1lez-Regueiro","year":"2017","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.gastha.2021.12.007_bib13","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/dom.12648","article-title":"Effect of chenodeoxycholic acid and the bile acid sequestrant colesevelam on glucagon-like peptide-1 secretion","volume":"18","author":"Hansen","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.gastha.2021.12.007_bib14","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1210\/jc.2016-1133","article-title":"Cholecystokinin-induced gallbladder emptying and metformin elicit additive glucagon-like peptide-1 responses","volume":"101","author":"Rohde","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.gastha.2021.12.007_bib15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","article-title":"TGR5-mediated bile acid sensing controls glucose homeostasis","volume":"10","author":"Thomas","year":"2009","journal-title":"Cell Metab"},{"key":"10.1016\/j.gastha.2021.12.007_bib16","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1093\/clinchem\/44.5.991","article-title":"Accurate measurement of cholecystokinin in plasma","volume":"44","author":"Rehfeld","year":"1998","journal-title":"Clin Chem"},{"key":"10.1016\/j.gastha.2021.12.007_bib17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/00365517209081114","article-title":"Production and evaluation of antibodies for the radioimmunoassay of gastrin","volume":"30","author":"Rehfeld","year":"1972","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.gastha.2021.12.007_bib18","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1530\/EJE-13-0941","article-title":"Specificity and sensitivity of commercially available assays for glucagon and oxyntomodulin measurement in humans","volume":"170","author":"Bak","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.gastha.2021.12.007_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0167-0115(84)90005-3","article-title":"The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera","volume":"9","author":"Krarup","year":"1984","journal-title":"Regul Pept"},{"key":"10.1016\/j.gastha.2021.12.007_bib20","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2337\/diab.43.4.535","article-title":"Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans","volume":"43","author":"Orskov","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/j.gastha.2021.12.007_bib21","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1097\/MEG.0000000000000476","article-title":"Diagnosis of bile acid diarrhoea by fasting and postprandial measurements of fibroblast growth factor 19","volume":"27","author":"Borup","year":"2015","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2021.12.007_bib22","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/ijo.2016.46","article-title":"Influence of Roux-en-Y gastric bypass on plasma bile acid profiles: a comparative study between rats, pigs and humans","volume":"40","author":"Spinelli","year":"2016","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.gastha.2021.12.007_bib23","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1210\/jc.2017-01397","article-title":"Bile acid alterations are associated with insulin resistance, but not with NASH, in obese subjects","volume":"102","author":"Legry","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.gastha.2021.12.007_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jnim.2015.11.002","article-title":"Cheese intake lowers plasma cholesterol concentrations without increasing bile acid excretion","volume":"3","author":"Hjerpsted","year":"2016","journal-title":"J\u00a0Nutr Intermed Metab"},{"key":"10.1016\/j.gastha.2021.12.007_bib25","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1093\/bioinformatics\/bty149","article-title":"NanoPack: visualizing and processing long-read sequencing data","volume":"34","author":"De Coster","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.gastha.2021.12.007_bib26","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nmeth.f.303","article-title":"QIIME allows analysis of high-throughput community sequencing data","volume":"7","author":"Caporaso","year":"2010","journal-title":"Nat Methods"},{"key":"10.1016\/j.gastha.2021.12.007_bib27","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/ismej.2011.139","article-title":"An improved Greengenes taxonomy with explicit ranks for ecological and evolutionary analyses of bacteria and archaea","volume":"6","author":"McDonald","year":"2012","journal-title":"ISME J"},{"key":"10.1016\/j.gastha.2021.12.007_bib28","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2214\/ajr.145.5.1009","article-title":"Sonographic measurement of gallbladder volume","volume":"145","author":"Dodds","year":"1985","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.gastha.2021.12.007_bib29","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4082\/kjfm.2016.37.3.188","article-title":"Comparison of surrogate markers as measures of uncomplicated insulin resistance in Korean adults","volume":"37","author":"Kim","year":"2016","journal-title":"Korean J Fam Med"},{"key":"10.1016\/j.gastha.2021.12.007_bib30","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2337\/diacare.24.3.460","article-title":"Diagnosing insulin resistance in the general population","volume":"24","author":"McAuley","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/j.gastha.2021.12.007_bib31","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1530\/EJE-14-0309","article-title":"Postprandial gallbladder emptying in patients with type 2 diabetes: potential implications for bile-induced secretion of glucagon-like peptide 1","volume":"171","author":"Sonne","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.gastha.2021.12.007_bib32","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","article-title":"Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2","volume":"37","author":"Bolyen","year":"2019","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.gastha.2021.12.007_bib33","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","article-title":"Metagenomic biomarker discovery and explanation","volume":"12","author":"Segata","year":"2011","journal-title":"Genome Biol"},{"key":"10.1016\/j.gastha.2021.12.007_bib34","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1136\/gut.43.6.812","article-title":"Biliary lipid composition in idiopathic bile acid malabsorption","volume":"43","author":"Fracchia","year":"1998","journal-title":"Gut"},{"key":"10.1016\/j.gastha.2021.12.007_bib35","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2982.2012.01893.x","article-title":"Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome","volume":"24","author":"Duboc","year":"2012","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.gastha.2021.12.007_bib36","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.14309\/ajg.0000000000000772","article-title":"Biochemical diagnosis of bile acid diarrhea: prospective comparison with the 75Seleno-taurohomocholic acid test","volume":"115","author":"Borup","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.gastha.2021.12.007_bib37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00042737-199602000-00005","article-title":"Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea","volume":"8","author":"Brydon","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.gastha.2021.12.007_bib38","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.gastha.2021.12.007_bib39","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","article-title":"Bile acids: natural ligands for an orphan nuclear receptor","volume":"284","author":"Parks","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.gastha.2021.12.007_bib40","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1101\/gad.1083503","article-title":"Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis","volume":"17","author":"Holt","year":"2003","journal-title":"Genes Dev"},{"key":"10.1016\/j.gastha.2021.12.007_bib41","doi-asserted-by":"crossref","first-page":"27277","DOI":"10.1074\/jbc.M704244200","article-title":"Liver-specific activities of FGF19 require Klotho beta","volume":"282","author":"Lin","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.gastha.2021.12.007_bib42","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2165\/11584310-000000000-00000","article-title":"A\u00a050-week extension study on the safety and efficacy of colesevelam in adults with primary hypercholesterolemia","volume":"10","author":"Davidson","year":"2010","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.gastha.2021.12.007_bib43","first-page":"1043","article-title":"Antidiabetogenic action of cholecystokinin-8 in type 2 diabetes","volume":"85","author":"Ahr\u00e9n","year":"2000","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.gastha.2021.12.007_bib44","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/dom.13080","article-title":"The bile acid-sequestering resin sevelamer eliminates the acute GLP-1 stimulatory effect of endogenously released bile acids in patients with type 2 diabetes","volume":"20","author":"Br\u00f8nden","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.gastha.2021.12.007_bib45","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1055\/s-2004-826158","article-title":"On the physiology of GIP and GLP-1","volume":"36","author":"Holst","year":"2004","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.gastha.2021.12.007_bib46","doi-asserted-by":"crossref","first-page":"7629","DOI":"10.1038\/ncomms8629","article-title":"Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells","volume":"6","author":"Trabelsi","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.gastha.2021.12.007_bib47","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1007\/s00125-012-2593-2","article-title":"Rectal taurocholate increases L cell and insulin secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers","volume":"55","author":"Adrian","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.gastha.2021.12.007_bib48","doi-asserted-by":"crossref","first-page":"102759","DOI":"10.1016\/j.ebiom.2020.102759","article-title":"Ileo-colonic delivery of conjugated bile acids improves glucose homeostasis via colonic GLP-1-producing enteroendocrine cells in human obesity and diabetes","volume":"55","author":"Calderon","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.gastha.2021.12.007_bib49","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/dom.12043","article-title":"Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humans","volume":"15","author":"Wu","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.gastha.2021.12.007_bib50","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/BF01296408","article-title":"Dissociation of cholecystokinin and pancreaticobiliary response to intraduodenal bile acids and cholestyramine in humans","volume":"36","author":"Koop","year":"1991","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.gastha.2021.12.007_bib51","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1210\/jc.2018-01008","article-title":"New avenues in the regulation of gallbladder motility-implications for the use of glucagon-like peptide-derived drugs","volume":"104","author":"Gether","year":"2019","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.gastha.2021.12.007_bib52","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1507\/endocrj.EJ18-0372","article-title":"Basal glucagon hypersecretion and response to oral glucose load in prediabetes and mild type 2 diabetes","volume":"66","author":"Ichikawa","year":"2019","journal-title":"Endocr J"},{"key":"10.1016\/j.gastha.2021.12.007_bib53","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/19490976.2015.1127483","article-title":"Consequences of bile salt biotransformations by intestinal bacteria","volume":"7","author":"Ridlon","year":"2016","journal-title":"Gut Microbes"},{"key":"10.1016\/j.gastha.2021.12.007_bib54","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MOG.0000000000000057","article-title":"Bile acids and the gut microbiome","volume":"30","author":"Ridlon","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.gastha.2021.12.007_bib55","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1053\/j.gastro.2019.11.301","article-title":"Differences in fecal microbiomes and metabolomes of people with vs without irritable bowel syndrome and bile acid malabsorption","volume":"158","author":"Jeffery","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.gastha.2021.12.007_bib56","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1194\/jlr.M075143","article-title":"Comprehensive evaluation of the bactericidal activities of free bile acids in the large intestine of humans and rodents","volume":"58","author":"Watanabe","year":"2017","journal-title":"J\u00a0Lipid Res"},{"key":"10.1016\/j.gastha.2021.12.007_bib57","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.3389\/fmicb.2018.01153","article-title":"In\u00a0vitro modeling of bile acid processing by the human fecal microbiota","volume":"9","author":"Martin","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.gastha.2021.12.007_bib58","doi-asserted-by":"crossref","first-page":"10641","DOI":"10.1007\/s00253-020-10976-3","article-title":"The effect of bile acids on the growth and global gene expression profiles in Akkermansia muciniphila","volume":"104","author":"Hagi","year":"2020","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.gastha.2021.12.007_bib59","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.3389\/fmicb.2017.01765","article-title":"Next-generation beneficial microbes: the case of Akkermansia muciniphila","volume":"8","author":"Cani","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.gastha.2021.12.007_bib60","doi-asserted-by":"crossref","first-page":"102590","DOI":"10.1016\/j.ebiom.2019.11.051","article-title":"Role of gut microbiota in type 2 diabetes pathophysiology","volume":"51","author":"Gurung","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.gastha.2021.12.007_bib61","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41522-019-0101-x","article-title":"Blautia genus associated with visceral fat accumulation in adults 20-76 years of age","volume":"5","author":"Ozato","year":"2019","journal-title":"NPJ Biofilms Microbiomes"},{"key":"10.1016\/j.gastha.2021.12.007_bib62","doi-asserted-by":"crossref","first-page":"12672","DOI":"10.1073\/pnas.1904099116","article-title":"Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn's disease, produces an inflammatory polysaccharide","volume":"116","author":"Henke","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.gastha.2021.12.007_bib63","doi-asserted-by":"crossref","first-page":"571731","DOI":"10.3389\/fimmu.2020.571731","article-title":"Gut microbiota as a trigger for metabolic inflammation in obesity and type 2 diabetes","volume":"11","author":"Scheithauer","year":"2020","journal-title":"Front Immunol"}],"container-title":["Gastro Hep Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572322000012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772572322000012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T11:32:49Z","timestamp":1757417569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772572322000012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"alternative-id":["S2772572322000012"],"URL":"https:\/\/doi.org\/10.1016\/j.gastha.2021.12.007","relation":{},"ISSN":["2772-5723"],"issn-type":[{"value":"2772-5723","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enterohepatic, Gluco-metabolic, and Gut Microbial Characterization of Individuals With Bile Acid Malabsorption","name":"articletitle","label":"Article Title"},{"value":"Gastro Hep Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gastha.2021.12.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute","name":"copyright","label":"Copyright"}]}}